The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis’ was the top ranked grant application in the NHMRC’s 2021 Clinical Trials and Cohort Studies grant scheme.
Professor Greg Fox honoured in NHMRC Research Excellence Awards
Updated: Jul 19, 2023
Comments